Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
FE$46.87+0.47(+1.01%)FirstEnergy Foundation Increases Support for Shelter, Safety and Stability The FirstEnergy Foundation has awarded $120,000 to 10 New Jersey nonprofit organizations that provide emergency shelter, housing assistance and...[2:15:00 PM ET]ORN$8.44+0.14(+1.69%)Orion Group Holdings Announces New Contract Awards of $250 Million[2:08:22 PM ET]MAPPF$0.10-0.00(-2.86%)ProStar CEO Michael Wolff Outlines Growth Strategy After First 90 Days[2:01:00 PM ET]SMX$1.82+0.04(+2.04%)MEDIA ALERT: TechCrunch Publishes Feature on SMX's Digital Material Identity Technology[2:00:00 PM ET]BJRI$63.46+2.95(+4.88%)BJ's Restaurant & Brewhouse Goes 'Bananas' with the New Nutella® Gone Bananas Pizookie® BJ's Restaurant & Brewhouse (NASDAQ: BJRI) is going bananas, and is bringing the whole table along! Introducing the Nutella® Gone Bananas Pizookie®,...[1:52:00 PM ET]DLTH$4.39+0.16(+3.78%)Best Workwear for Durability and Weather Protection? Duluth Trading Expands Fire Hose® Workwear with New Waxed Styles[1:50:00 PM ET]DCOM$42.20+0.34(+0.81%)Dime Commercial Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock[1:40:23 PM ET]TECK$63.61+0.57(+0.90%)Teck Announces Dividend[1:35:50 PM ET]UFPT$291.88+5.88(+2.06%)UFP Technologies to Report Third Quarter 2026 Financial Results on November 3, 2026[1:34:00 PM ET]

PLSE · NASDAQ

Pulse Biosciences, Inc.

$55.86 +2.28 (+4.26%)

Company overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers the CellFX System, a tunable, software-enabled, console-based platform that delivers nanosecond duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat various medical conditions using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences was incorporated in 2014 and is headquartered in Hayward, California.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Market cap
$4B
Employees
75
Headquarters
Miami, CA
Website
pulsebiosciences.com
CEO
Paul Arthur LaViolette
Listed
May 18, 2016
P/E
-51.30
Dividend yield
0.00%

Company financials

Revenue
$751,000
Gross profit
-$684,000
Operating income
-$78M
EBITDA
-$73.8M
Net income
-$74.6M
EPS
-$1.09
Total assets
$81.6M
Total debt
$7.2M
Gross margin
-91.08%
Net margin
-9,929.03%
Earnings yield
-1.95%

Revenue segmentation

By product (FY 2022)
By region (FY 2022)

Showing FY 2022

Price chart

16.7427.6838.6349.5860.52
PLSE 1D NASDAQ O53.12H54.73L52.76C53.67+0.47 (+0.88%)Vol280.00K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences to Present at Stifel 2026 Healthcare Conference Business Wire
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026 Business Wire
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center Business Wire
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences' nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026 Business Wire
PLSEPulse Biosciences, Inc. Stock news Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment Business Wire
TLSI Stock news TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday Benzinga
PLSEPulse Biosciences, Inc. Stock news This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Benzinga
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules Business Wire
AVAV Stock news Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday Benzinga
PLSEPulse Biosciences, Inc. Stock news Why Pulse Biosciences Stock Popped Today The Motley Fool
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
PLSEPulse Biosciences, Inc. Stock news Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE Defense World
PLSEPulse Biosciences, Inc. Stock news This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Benzinga
PLSEPulse Biosciences, Inc. Stock news Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform MarketBeat
PLSEPulse Biosciences, Inc. Stock news Pulse Biosciences, Inc. (PLSE) Q2 2026 Earnings Call Transcript Seeking Alpha
PLSEPulse Biosciences, Inc. Stock news Pulse Biosciences Q2 Earnings Call Highlights MarketBeat
PLSEPulse Biosciences, Inc. Stock news Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates Zacks Investment Research
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results Business Wire
PLSEPulse Biosciences, Inc. Press release Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 Business Wire
PLSEPulse Biosciences, Inc. Stock news Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy Zacks Investment Research
See more
FAQ

Questions about Pulse Biosciences, Inc.

What does Pulse Biosciences, Inc. do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers the CellFX System, a tunable, software-enabled, console-based platform that delivers nanosecond duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat various medical conditions using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences was incorporated in 2014 and is headquartered in Hayward, California.
What is PLSE's market cap?
Pulse Biosciences, Inc. (PLSE) is a listed stock with a live quote. The latest market cap on this page is $4B.
Where is Pulse Biosciences, Inc. headquartered?
Pulse Biosciences, Inc. is headquartered in Miami, CA.
How do I get PLSE news from the API?
Call GET /v1/news?tickers=PLSE. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does PLSE news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for PLSE, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the PLSE price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs